Skip to main content
Premium Trial:

Request an Annual Quote

Aussie Cancer Center Buys Whole Genome Library from Open Biosystems as Part of Open Access Program

NEW YORK, July 6 (GenomeWeb News) - Australia's Peter MacCullum Cancer Centre purchased a license to Open Biosystems' whole genome human lentiviral shRNAmir library, the company said today.

 

The transaction was made through the company's Open Access RNAi Program. The program gives the hospital access to RNAi technology, updates and upgrades, off-site backups, and a partner-specific technical support team.

 

The whole-genome resource enables the hospital's 265 investigators to target any gene in the human genome with what Open Biosystems calls improved knockdown efficiency and effectiveness.

 

Financial details were not disclosed.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.